How Medicines Law & Policy
is Aiding the Covid-19 Response
SEE COVID RESOURCES
European Union Review of Pharmaceutical Incentives:
Suggestions for Change
A new briefing paper series from Medicines Law & Policy
READ MORE
EU Review of Pharmaceutical
Incentives: Suggestions for Change
Medicines Law & Policy creates tools countries and others looking to increase access to medicines can use to overcome patent barriers when needed.
OUR TOOLS
Medicines Law & Policy maintains a database
documenting use of TRIPS Flexibilities
to increase access to medicines worldwide.
ACCESS THE TRIPS FLEXIBILITIES DATABASE
Medicines Law & Policy releases analysis,
policy recommendations and tools to aid practitioners
working on universal access to medicines.
OUR RESOURCES

Latest insight from Medicines Law & Policy

Wrapping up 2021 – some noteworthy medicines law and policy events

Ellen 't Hoen -
Welcome to the annual end of the year blog, our highly biased overview of noteworthy events in the field of medicines law and policy....

Landmark decision by the World Health Assembly to start negotiations for a pandemic treaty

Kaitlin Mara -
GENEVA, SWITZERLAND: World Health Organization (WHO) member states today decided to pursue an agreement that can better prepare the world to face future pandemics....

Imagine if health and trade ministers would meet in one room this week

Ellen 't Hoen -
A earlier version of this commentary was published on 28 November 2021 by Barron's. This is a time of missed opportunities. This week, trade ministers...

The WHO Covid-19 Technology Access Pool signs first licence agreement; will hopefully be a...

Kaitlin Mara -
The Covid-19 Technology Access Pool (C-TAP), a World Health Organization initiative launched in May 2020 to facilitate the sharing of technology, intellectual property and...

A second Covid-19 treatment will now be made available through the Medicines Patent Pool

Medicines Law & Policy -
The Medicines Patent Pool, a United Nations-backed public health organisation, today announced its second Covid-related voluntary licence agreement. The agreement will enable low-cost production...

Medicines Patent Pool signs first Covid-19 licence agreement with Merck Sharp & Dohme. Others...

Medicines Law & Policy -
The Medicines Patent Pool, a UN-backed organisation whose mission is to expand access to essential medicines around the world, today announced its first agreement...

Subscribe to Our Newsletter

Never miss a post! Sign up for ML&P's mailing list by entering your information below. The list will only be used to inform you of new content (messages are sent approximately once a month).

Posts by Subject

Access to Medicines ARIPO C-TAP Cancer CDCA competition law Compulsory licensing compulsory licensing for export covid-19 Covid-19 Pool Covid-19 vaccine Data exclusivity Delinkage DNDi dolutegravir essential medicines list European Commission European Union evergreening Fair Pricing Gilead Hepatitis C HIV IFPMA LDCs market exclusivity Medicines Patent Pool Medicines Pricing Netherlands orkambi Orphan Drugs Patents PrEP R&D remdesivir Sofosbuvir SPC Supplementary Protection Certificates The Netherlands TRIPS flexibilities Truvada vaccines WHO WIPO WTO
 This work is licensed under Creative Commons.